They just received FDA approval on their non-MRNA Covid vaccine yesterday, and the stock was halted all day so nobody's been able to buy it yet. It should have a big pop when it starts trading today.
The stock is way down from the highs because of how long it's taken them to get approval. But the company is estimating $4B – $5B in sales this year.
Leave a Reply